Topics covered: Tactical Growth and Tactical Moderate Investment Strategies, Investing in MLPs, Income Exempt from Federal Tax, Fundamental Value Investing, Conservative and Flexible Portfolio Management, Absolute Performance Through Multiple Asset Classes
Companies covered: Alkermes plc (NASDAQ:ALKS), Walgreen Co., Unilever PLC (NYSE:UL), Safeway Inc. (NYSE:SWY), Sanofi (NYSE:SNY), Rite Aid Corporation (NYSE:RAD), Insulet Corporation (NASDAQ:PODD), Novo Nordisk A/S (NYSE:NVO), Novartis AG (NYSE:NVS), Merck & Company, Inc. (NYSE:MRK), Eli Lilly and Company (NYSE:LLY), Kraft Foods Inc., GlaxoSmithKline PLC (NYSE:GSK), DexCom, Inc. (NASDAQ:DXCM), CVS Health Corporation (NYSE:CVS), Bristol-Myers Squibb Company (NYSE:BMY), AstraZeneca PLC (NASDAQ:AZN), Amylin Pharmaceuticals Inc., Wendy's Company (The) (NASDAQ:WEN), Teva Pharmaceutical Industries Limited (NYSE:TEVA), AT&T Inc. (NYSE:T), Paychex, Inc. (NASDAQ:PAYX), Liberty Media Interactive, Coca-Cola Company (The) (NYSE:KO), Kinder Morgan Energy Partners, Johnson & Johnson (NYSE:JNJ), Cablevision Systems Corporation (NYSE:CVC), Clorox Company (The) (NYSE:CLX), The AES Corporation (NYSE:AES), Calamos Asset Management, Inc. (NASDAQ:CLMS), Walmart Inc. (NYSE:WMT), Washington Federal Inc., T. Rowe Price Group, Inc. (NASDAQ:TROW), CNA Surety Corp., Franklin Resources, Inc. (NYSE:BEN), American International Group, Inc. (NYSE:AIG)
